BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28512114)

  • 1. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
    Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
    PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H
    Khawaja M; Thakker J; Kherallah R; Kitakaze M; Jneid H; Angiolillo DJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2024 Feb; 38(1):181-189. PubMed ID: 35715526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between acid-suppressive drug use and atopic dermatitis in patients with upper gastrointestinal diseases: A population-based retrospective cohort study.
    Lin HC; Chen YY; Lin HL; Uang YS; Ho Y; Wang LH
    J Clin Pharm Ther; 2021 Jun; 46(3):786-793. PubMed ID: 33403692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events.
    Li X; Klompas M; Menchaca JT; Young JG
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):187-193. PubMed ID: 31818336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
    Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
    Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients.
    Chen C; Liu H; Duan R; Wang F; Duan L
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2131-2140. PubMed ID: 33586808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.
    Papagerakis S; Bellile E; Peterson LA; Pliakas M; Balaskas K; Selman S; Hanauer D; Taylor JM; Duffy S; Wolf G
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1258-69. PubMed ID: 25468899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study.
    Ruigómez A; Johansson S; Nagy P; García Rodríguez LA
    Curr Med Res Opin; 2017 Dec; 33(12):2201-2209. PubMed ID: 28699796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?
    Hashimoto H; Kushikata T; Kudo M; Hirota K
    J Gastroenterol; 2007 Apr; 42(4):275-8. PubMed ID: 17464455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.